Skip to main content

SYSTEMATIC REVIEW article

Front. Physiol.
Sec. Integrative Physiology
Volume 15 - 2024 | doi: 10.3389/fphys.2024.1423567

A Scoping Review of Preclinical Intensive Care Unit-Acquired Weakness Models

Provisionally accepted
Qingmei Yu Qingmei Yu 1,2Jiamei Song Jiamei Song 1,2Luying Yang Luying Yang 2,3Yanmei Miao Yanmei Miao 2,3Leiyu Xie Leiyu Xie 3Xinglong Ma Xinglong Ma 3Peng Xie Peng Xie 4*Shaolin Chen Shaolin Chen 1,2*
  • 1 Nursing Department, Affiliated Hospital of Zunyi Medical University, Zunyi, China
  • 2 School of Nursing, Zunyi Medical University, Zunyi, Guizhou Province, China
  • 3 Department of Critical Care Medicine, First People’s Hospital of Zunyi, Zunyi, Guizhou Province, China
  • 4 Department of Critical Care Medicine, Hengyang Medical College, University of South China, Hengyang, Hunan Province, China

The final, formatted version of the article will be published soon.

    Background: Animal models focusing on neuromuscular outcomes are crucial for understanding the mechanisms of intensive care unit-acquired weakness (ICU-AW) and exploring potential innovative prevention and treatment strategies.To analyse and evaluate preclinical ICU-AW models.: We manually searched five English and four Chinese databases from January 1, 2002, to February 1, 2024, and reviewed related study references. Full-text publications describing animal models of muscle weakness and atrophy in critical illness were included. Detailed information about model types, animal species, sex, age, induction methods, outcome measures, drawbacks and strengths was extracted from each included study. Results: A total of 3451 citations were initially retrieved, with 84 studies included in the final analysis. The most frequently studied animal model included rodents (86.9%), 64.3% of which were male animals. ICU-AW animal models were mostly induced by comprehensive intensive care unit (ICU) interventions (38.1%) and sepsis (51.2%). Most studies focused on limb muscles (66.7%), diaphragm muscles (21.4%) or both (9.5%). Reported outcomes primarily included muscular pathological changes (83.3%), electrophysiological examinations of muscles (57.1%) and animal grip strength (16.6%). However, details such as animal age, mortality data, experimental design, randomisation, blinding, sample size and interventions for the experimental group and/or control group were inadequately reported. Conclusion: Many preclinical models are used to study ICU-AW, but the reporting of methodological details is often incomplete. Although current ICU animal models can mimic the characteristics of human ICU-AW, there is no standard model. Future preclinical studies should develop a standard ICU-AW animal model to enhance reproducibility and improve scientific rigor in exploring the mechanisms and potential treatment of ICU-AW.

    Keywords: intensive care unit-acquired weakness, ICU-acquired weakness, animal model, Muscle Weakness, muscle atrophy, Scoping review

    Received: 26 Apr 2024; Accepted: 23 Sep 2024.

    Copyright: © 2024 Yu, Song, Yang, Miao, Xie, Ma, Xie and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Peng Xie, Department of Critical Care Medicine, Hengyang Medical College, University of South China, Hengyang, 421001, Hunan Province, China
    Shaolin Chen, Nursing Department, Affiliated Hospital of Zunyi Medical University, Zunyi, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.